|
State
|
Current situation
|
Screening
|
Promotion of hygiene
|
|---|
|
Best (%)
|
Minimum (%)
|
Maximum (%)
|
Best (%)
|
Minimum (%
|
Maximum (%)
|
Best (%)
|
Minimum (%
|
Maximum (%)
|
|---|
|
CMV seronegative
|
435,200 (54.4)
|
598,400 (74.8)
|
312,000 (39.0)
|
433,683 (54.2)
|
595,414 (74,4)
|
310,128 (38,8)
|
435,200 (54.4)
|
598,400 (74.8)
|
312,000 (39.0)
|
|
MPI
|
4352 (0.54)
|
1197 (0.15)
|
4368 (0.55)
|
3018 (0.38)
|
1270 (0.16)
|
3069 (0.38)
|
2176 (0.27)
|
598 (0.07)
|
2184 (0.27)
|
|
Foetal infection in CMV-
|
1741 (0.22)
|
60 (0.0008)
|
3154 (0.39)
|
1741 (0.22)
|
60 (0.008)
|
3154 (0.39)
|
870 (0.11)
|
30 (0.004)
|
1577 (0.20)
|
|
CMV seropositive
|
364,800 (49.6)
|
201,600 (25.2)
|
488,000 (61.0)
|
366,317 (45.8)
|
204,586 (25.6)
|
488,408 (61,1)
|
364,800 (45.6)
|
201,600 (25.2)
|
488,000 (61.0)
|
|
Foetal infection after RI
|
1699 (0.21)
|
1540 (0.19)
|
1726 (0.22)
|
1699 (0.21)
|
1540 (0.19)
|
1726 (0.22)
|
1699 (0.21)
|
1540 (0.19)
|
1726 (0.22)
|
|
Total foetal infections
|
3440 (0.43)
|
1600 (0.20)
|
4880 (0.61)
|
3440 (0.43)
|
1600 (0.20)
|
4880 (0.61)
|
2569 (0.32)
|
1570 (0.20)
|
3303 (0.41)
|
|
Deaths & TOP
|
316 0.040)
|
147 (0.018)
|
449 (0.056)
|
919 (0.12)
|
183 (0.023)
|
1968 (0.25)
|
236 (0.030)
|
144 (0.018)
|
304 (0.038)
|
|
Total congenital infections
|
3123 (0.39)
|
1453 (0.18)
|
4431 (0.55)
|
2522 (0.32)
|
1417 (0.18)
|
2913 (0.36)
|
2333 (0.29)
|
1425 (0.18)
|
2999 (0.37)
|
|
Symptomatic in RI
|
60 (0.008)
|
54 (0.007)
|
60 (0.008)
|
60 (0.008)
|
54 (0.007)
|
60 (0.008)
|
60 (0.008)
|
54 (0.007)
|
60 (0.008)
|
|
Symptomatic in MPI
|
60 (0.008)
|
2 (< 0.001)
|
110 (0.014)
|
41 (0.005)
|
1 (< 0.001)
|
61 (0.008)
|
30 (0.004)
|
1 (< 0.001)
|
55 (0.007)
|
|
Severe symptomatic
|
60 (0.008)
|
28 (0.004)
|
85 (0.011)
|
50 (0.006)
|
27 (0,003)
|
60 (0.008)
|
45 (0.006)
|
27 (0,003)
|
58 (0.007)
|
|
Moderate symptomatic
|
60 (0.008)
|
28 (0.004)
|
85 (0.011)
|
50 (0.006)
|
27 (0,003)
|
60 (0.008)
|
45 (0.006)
|
27 (0,003)
|
58 (0.007)
|
|
Sequelae asymptom. RI
|
197 (0.025)
|
179 (0.022)
|
200 (0.025)
|
197 (0.025)
|
179 (0.022)
|
200 (0.025)
|
197 (0.025)
|
179 (0.022)
|
200 (0.025)
|
|
Sequelae asymptom. MPI
|
202 (0.025)
|
7 (< 0.001)
|
366 (0.05)
|
125 (0.016)
|
2 (< 0.001)
|
171 (0,022)
|
101 (0.013)
|
3 (< 0.001)
|
183 (0.023)
|
|
Severe sequela (symptom)
|
48 (0.006)
|
22 (0.003)
|
68 (0.009)
|
40 (0.005)
|
22 (0.003)
|
48 (0.006)
|
36 (0.005)
|
22 (0.003)
|
46 (0.006)
|
|
Mod. sequelae (symptom)
|
35 (0.004)
|
11 (0.001)
|
35 (0.004)
|
21 (0.003)
|
11 (0.001)
|
25 (0.003)
|
18 (0.002)
|
11 (0.001)
|
24 (0.003)
|
|
Total poor outcomes
|
788 (0.099)
|
367 (0.046)
|
1119 (0.14)
|
1301 (0.16)
|
397 (0.050)
|
2413 (0.30)
|
588 (0.074)
|
356 (0.045)
|
757 (0.095)
|
- CMV cytomegalovirus; RI recurrent infection in CMV seropositive mothers; MPI maternal primary infection; CMV- mothers who are CMV seronegative before pregnancy; TOP termination of pregnancy; asymptom.: if asymptomatic at birth; Mod.: moderate; symptom: if symptomatic at birth
